Here Is What Hedge Funds Think About OM Asset Management PLC (OMAM)

Page 2 of 2

As one would reasonably expect, key money managers have jumped into OM Asset Management PLC (NYSE:OMAM) headfirst. Tudor Investment Corp, led by Paul Tudor Jones, initiated the most valuable position in OM Asset Management PLC (NYSE:OMAM). Tudor Investment Corp had $0.6 million invested in the company at the end of the quarter. Peter Rathjens, Bruce Clarke and John Campbell’s Arrowstreet Capital also initiated a $0.3 million position during the quarter. The only other fund with a brand new OMAM position is John Overdeck and David Siegel’s Two Sigma Advisors.

Let’s now take a look at hedge fund activity in other stocks similar to OM Asset Management PLC (NYSE:OMAM). These stocks are ExlService Holdings, Inc. (NASDAQ:EXLS), USANA Health Sciences, Inc. (NYSE:USNA), Core-Mark Holding Company, Inc. (NASDAQ:CORE), and Northwest Natural Gas Co (NYSE:NWN). All of these stocks’ market caps are similar to OMAM’s market cap.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
EXLS 8 56257 -5
USNA 14 142282 1
CORE 14 57732 -3
NWN 12 53058 -2

As you can see these stocks had an average of 12 hedge funds with bullish positions and the average amount invested in these stocks was $77 million. That figure was $64 million in OMAM’s case. USANA Health Sciences, Inc. (NYSE:USNA) is the most popular stock in this table. On the other hand ExlService Holdings, Inc. (NASDAQ:EXLS) is the least popular one with only eight bullish hedge fund positions. OM Asset Management PLC (NYSE:OMAM) is not the least popular stock in this group but hedge fund interest is still below average. This is a slightly negative signal and we’d rather spend our time researching stocks that hedge funds are piling on. In this regard USANA Health Sciences might be a better candidate to consider taking a long position in.

Suggested Articles:
Deadliest Dog Breeds
Countries That Produce The Best Doctors
Countries With The Highest Atheist Population

Disclosure: None




Page 2 of 2